In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...

Cell therapy biotech bit.bio is slimming its workforce by 25% as the company pivots to focus on biomedical tools instead of ...

Innovative product line is purpose-built to streamline the manufacture of allogeneic cell therapies. Available exclusively from Teknova starting today.HOLLISTER, Calif., March 19, 2025 (GLOBE NEWSWIRE ...

Oncologists are increasingly favoring CAR T-cell therapy’s early-line use in relapsed/refractory multiple myeloma despite challenges like cost and access.

If your dog could live longer, wouldn't you go for it? This product may be making this possibility a reality (and could help humans too!).

In this interview, News Medical speaks with Olivier Negre, Chief Scientific Officer at Smart Immune, about how immunotherapy is being revolutionized.

Dr. Dina Radenkovic, CEO of Gameto, identifies strategies to close the gap in women's health and how we can better incentivize research and development in this area.

Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related mortality worldwide. Current treatment modalities are few or ...

Using an unbiased approach, this important study discovered a role of Ezh2 in the differentiation of granule neuron precursors, the cell of origin for Shh group of medulloblastoma. Furthermore, the ...

Dr. Dina Radenkovic, CEO of Gameto, identifies the main contributors to the gap in in women's health innovation.

Bristol Myers Squibb gets European Commission approval to expand use of CAR T cell therapy, Breyanzi for relapsed or refractory follicular lymphoma: Princeton, New Jersey Monday, ...

Lyell Immunopharma, Inc.’s LYEL share price has dipped by 11.67%, which has investors questioning if this is right time to buy.